Informed consent is a fundamental aspect of GCP, ensuring that participants are fully aware of the trial's purpose, procedures, potential risks, and benefits. In cancer trials, this process is particularly crucial as treatments can be intensive and carry significant risks. Participants must be given ample time to consider their participation and have their questions answered thoroughly.
